NASDAQ: AVTX Shareholder Notice: Investigation Over Possible Securities Laws Violations by Avalo Therapeutics, Inc.

An investigation for investors in Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares over potential securities laws violations by Avalo Therapeutics, Inc. was announced.

San Diego, CA — (SBWIRE) — 02/04/2022 — Avalo Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Avalo Therapeutics, Inc. (NASDAQ: AVTX) in mid 2019 or earlier and continue to hold any of their NASDAQ: AVTX shares, have certain options. Please contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Avalo Therapeutics, Inc. (NASDAQ: AVTX) concerning whether a series of statements by Avalo Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Rockville, MD based Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases.

Shares of Avalo Therapeutics, Inc. (NASDAQ: AVTX) declined from $5.71 per share in December 2019 to as low as $1.7 per share in March 2020.

Avalo Therapeutics, Inc. reported that its annual Total Revenue declined from $6.75 million in 2019 to $6.69 million in 2020, and that its Net Loss increased from $16.07 million in 2019 to $63.50 million in 2020.

Those who purchased shares of Avalo Therapeutics, Inc. (NASDAQ: AVTX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/nasdaq-avtx-shareholder-notice-investigation-over-possible-securities-laws-violations-by-avalo-therapeutics-inc-1352730.htm

Media Relations Contact

Michael Daniels
Shareholders Foundation, Inc.
Telephone: 1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com